Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high‐dose cyclophosphamide and peripheral stem cell support: An Australian and New Zealand children's hematology and oncology group study
- DOI
- 10.1002/pbc.23042
- Published
- 2011-07-25
- Container
- Pediatric Blood & Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/pbc.23042,
title = {Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high‐dose cyclophosphamide and peripheral stem cell support: An Australian and New Zealand children's hematology and oncology group study},
author = {Geoffrey B. McCowage and Robert Mrongovius and Frank Alvaro and Richard J. Cohn and David S. Ziegler and Cecilia Oswald and Les White and Unknown},
year = {2011},
journal = {Pediatric Blood \& Cancer},
doi = {10.1002/pbc.23042},
url = {https://doi.org/10.1002/pbc.23042}
}RIS
TY - JOUR TI - Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high‐dose cyclophosphamide and peripheral stem cell support: An Australian and New Zealand children's hematology and oncology group study AU - Geoffrey B. McCowage AU - Robert Mrongovius AU - Frank Alvaro AU - Richard J. Cohn AU - David S. Ziegler AU - Cecilia Oswald AU - Les White AU - Unknown PY - 2011 JO - Pediatric Blood & Cancer DO - 10.1002/pbc.23042 UR - https://doi.org/10.1002/pbc.23042 ER -
APA
McCowage, G. B., Mrongovius, R., Alvaro, F., Cohn, R. J., Ziegler, D. S., Oswald, C., White, L., & Unknown (2011). Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high‐dose cyclophosphamide and peripheral stem cell support: An Australian and New Zealand children's hematology and oncology group study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.23042
Source records
- crossref · retrieved 2026-11-10T05:50:26.553Z